AngioDynamics, Inc.
AngioDynamics, Inc.（ANGO）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
ango · 股价预测 · 11 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Hold
11 位分析师
共识
评级分布
12 个月目标价
High
$22.00
Consensus
$16.50
+38.3% upside
Low
$12.00
Median: $16 · Last Close: $11.93
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$16.50
38.3% upside
High Target
$22
84.4%
Low Target
$12
0.6%
Current Price
$11.93
as of today
Based on analyst price targets, the ANGO stock price prediction for the next 12 months ranges from $12 to $22. The consensus ANGO price forecast of $16.50 implies 38.3% upside from the current price of $11.93.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $12.05 | ↑ 1.02% |
1-day model range: $12–$12.1. Peak: $12.1 (+1.02%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $12 | -1.3% |
| 2028 | $12 | -2.1% |
| 2029 | $12 | -2.5% |
| 2030 | $12 | -2.7% |
| 2031 | — | -2.8% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ANGO · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-06 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-10-03 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-07-16 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-07-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-09 | Canaccord Genuity | Maintains | Buy→Buy |
| 2024-12-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-10-04 | Canaccord Genuity | Maintains | Buy→Buy |
| 2024-10-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on AngioDynamics, Inc. (ANGO) stock. Of the recent 56 rating actions, 6 were upgrades and 6 were downgrades. 11 analysts currently cover ANGO.
分析师推荐趋势
ANGO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$314M
↓ 9.9% YoY
Revenue Next Year
$330M
↑ 4.9% YoY
EPS This Year
$-0.16
EPS Next Year
$-0.16
↓ 3.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast ANGO EPS of $-0.16 for the current fiscal year, based on estimates from 3 analysts. The ANGO revenue forecast is $314M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ANGO 股价预测由两类独立数据源支撑：来自 11 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ANGO 的共识目标价为 $16.50（+38.3% 上行空间），分析师共识为 Hold。
ANGO 的短期预测（明日）为 $12.05（+1.02%）。 ANGO 对 2027 年的股价预测均值为 $12。 ANGO 对 2030 年的预测区间为 $11–$12。
AngioDynamics, Inc. 在 NASDAQ 上市，代码 ANGO。ANGO 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 45% 对应 Hold 共识。
常见问题
ANGO 预测 · 8 个问题根据 11 位华尔街分析师，ANGO 的 12 个月平均目标价为 $16.50，最高 $22.00、最低 $12.00。若有图表，中位目标价可在上方查看。相对当前价 $11.93，隐含约 +38.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.